Jeff Duan
Fortune : 55 M $ au 30/09/2026
Fortune : 55 M $ au 30/09/2026
Ji Feng Duan is currently the Chief Executive Officer & Managing Director at PharmaLegacy Laboratories (Shanghai) Co., Ltd. since 2008.
Dr. Duan is also the Director at Shanghai OPM Biosciences Co. Ltd. starting in 2026.
The education history includes graduate studies at Tianjin Medical University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/08/2026 | 4 619 838 ( 18,46 % ) | 55 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SHANGHAI OPM BIOSCIENCES CO., LTD. | Directeur/Membre du Conseil | 27/02/2026 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Directeur Général | 07/03/2008 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Tianjin Medical University
Tianjin Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai OPM Biosciences Co. Ltd.
Shanghai OPM Biosciences Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces animal cell serum-free media for optimization and antibody drug identification and analysis | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national